Cargando…
Cardiac-Specific Deletion of Pyruvate Dehydrogenase Impairs Glucose Oxidation Rates and Induces Diastolic Dysfunction
Obesity and type 2 diabetes (T2D) increase the risk for cardiomyopathy, which is the presence of ventricular dysfunction in the absence of underlying coronary artery disease and/or hypertension. As myocardial energy metabolism is altered during obesity/T2D (increased fatty acid oxidation and decreas...
Autores principales: | Gopal, Keshav, Almutairi, Malak, Al Batran, Rami, Eaton, Farah, Gandhi, Manoj, Ussher, John Reyes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845646/ https://www.ncbi.nlm.nih.gov/pubmed/29560354 http://dx.doi.org/10.3389/fcvm.2018.00017 |
Ejemplares similares
-
Stimulating myocardial pyruvate dehydrogenase activity fails to alleviate cardiac abnormalities in a mouse model of human Barth syndrome
por: Greenwell, Amanda A., et al.
Publicado: (2022) -
The Impact of Antidiabetic Therapies on Diastolic Dysfunction and Diabetic Cardiomyopathy
por: Gopal, Keshav, et al.
Publicado: (2020) -
Pyruvate Dehydrogenase Complex and Glucose Oxidation as a Therapeutic Target in Diabetic Heart Disease
por: Tabatabaei Dakhili, Seyed Amirhossein, et al.
Publicado: (2023) -
Loss of muscle PDH induces lactic acidosis and adaptive anaplerotic compensation via pyruvate-alanine cycling and glutaminolysis
por: Gopal, Keshav, et al.
Publicado: (2023) -
Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
por: Echeverría, Luis E., et al.
Publicado: (2021)